Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | ($14.2M) | ($21.5M) | ($34.6M) | ($53.8M) | ($89.3M) | ($59.4M) | ($38.6M) | ($42.5M) | ($36.0M) | ($29.1M) | ($12.3M) | ($48.7M) | ($10.7M) | ($7,387.0K) | $27.4M | $22.1M | ($600.0K) | $66.7M | ($26.7M) | $220.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insulet Corporation's last 12-month Operating Income is $323.4M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insulet Corporation's Operating Income growth was 208.0%. The average annual Operating Income growth rates for Insulet Corporation have been 75.0% over the past three years, 46.4% over the past five years.
Over the last year, Insulet Corporation's Operating Income growth was 208.0%, which is higher than industry growth of (0.2%). It indicates that Insulet Corporation's Operating Income growth is Good.